Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Robert A Bradway
4 Mar 2026
Chairman, CEO and President
Exercised, kept
119,782
$156.35
$18.73M

What was left out

Form 4 filings counted 86
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 9
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 510,711
History held since 4 Oct 2006